4-(4-Aminophenoxy)-N-methylpicolinamide: Synthesis, Applications, and Pharmaceutical Potential
Discover the synthesis, mechanism, and potential of a key intermediate in the development of novel antitumor agents.
Get a Quote & SampleProduct Core Value
4-(4-Aminophenoxy)-N-methylpicolinamide
This compound is a crucial pharmaceutical intermediate, primarily recognized for its role in synthesizing advanced antitumor agents, including potent tyrosine kinase inhibitors. Its chemical structure allows for targeted interactions with key biological pathways involved in cancer proliferation.
- A vital component in medicinal chemistry research, facilitating the creation of targeted cancer therapies by acting as a key intermediate.
- Demonstrates significant potential as an antitumor agent itself, exhibiting antiproliferative activity against various cancer cell lines.
- Its mechanism of action targets the MET protein, a receptor tyrosine kinase critical for cell growth and survival, offering a pathway for developing new cancer treatments.
- The synthesis of this compound can be achieved through efficient methods like SNAr or palladium-catalyzed coupling, ensuring high purity and yield for research and development.
Key Advantages
High Purity for Reliable Research
Achieving high purity levels through optimized synthesis pathways ensures reliable and reproducible results in medicinal chemistry experiments. This is crucial when exploring the potential of 4-(4-Aminophenoxy)-N-methylpicolinamide as a MET inhibitor.
Versatile Intermediate for Drug Discovery
The structural versatility of 4-(4-Aminophenoxy)-N-methylpicolinamide makes it an excellent building block for synthesizing a wide array of novel drug candidates, aiding in the discovery of new treatments for various diseases.
Targeted Cancer Therapy Potential
Its ability to inhibit the MET protein kinase positions it as a promising candidate for developing targeted cancer therapies, offering a more precise approach to cancer treatment compared to traditional chemotherapy.
Key Applications
Antitumor Agent Research
Investigating its antiproliferative effects against cancer cell lines, like A549 and HeLa, is a primary application in the search for new cancer treatments.
Tyrosine Kinase Inhibitor Synthesis
Used as a critical intermediate in the synthesis of advanced drugs like Sorafenib, which target multiple receptor tyrosine kinases involved in cancer.
Medicinal Chemistry Studies
Exploring structure-activity relationships (SAR) by synthesizing derivatives to enhance MET kinase inhibition and improve pharmacokinetic properties.
Pharmaceutical Intermediate Manufacturing
Production of high-purity 4-(4-Aminophenoxy)-N-methylpicolinamide for use in large-scale pharmaceutical synthesis and drug development pipelines.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).